WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark PRÉNUMBRA was filed as Word mark on 08/11/2020 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1555226 |
| Register number | 018202301 |
| Countries | 
|
| Base trademark |
No. 018202301,
June 27, 2020
|
| Application date | August 11, 2020 |
| Expiration date | August 11, 2030 |
Trademark owner
Devonshire House, 60 Goswell Road
London EC1M 7AD
GB
London EC1M 7AD
GB
Trademark representatives
Thierschstr. 11
80538 München
DE
goods and services
05
Pharmaceuticals; pharmaceutical drugs; pharmaceutical
preparations; pharmaceuticals used for cerebrovascular
accidents (strokes); cardiovascular preparations;
cardiovascular pharmaceuticals; cardiovascular
pharmaceutical preparations; cardiovascular agents for
medical purposes; cardiovascular drugs used in treating
shocks; cardiovascular drugs used in myocardial infarctions;
cardiovascular drugs used in treating arrhythmias;
cardiovascular drugs used in angina pectoris; pharmaceutical
preparations for the treatment of cardiovascular disease;
cardiovascular drugs used in treating congestive heart
failure (CHF); pharmaceutical preparations, preferably based
on analogues of melanocyte stimulating hormone (MSH), in
particular afamelanotide; sun tanning preparations for
pharmaceutical purposes, preferably based on analogues of
melanocyte stimulating hormone (MSH), in particular
afamelanotide; pharmaceutical preparations for skin care;
pharmaceutical preparations for treating skin disorders;
dermatological preparations; dermatological pharmaceutical
substances; dermatological pharmaceutical products;
medicinal creams for the protection of the skin; skin care
creams for medical use; skin care preparations for medical
use; medicated skin creams and lotions; medicated creams for
application after exposure to the sun; pharmaceutical skin
lotions; preparations for cleansing the skin for medical
use; chemical and biological preparations, substances,
reagents and compounds for the delivery and storage of
pharmaceuticals which are preferably based on analogues of
melanocyte stimulating hormone (MSH), in particular
afamelanotide; afamelanotide aqueous and gel formulations
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 17, 2023 | 2023/21 Gaz | CA | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| May 17, 2023 | 2023/21 Gaz | CN | RAW: Rule 18ter(4) all goods and services protected |
| June 7, 2022 | 2022/23 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 24, 2022 | 2022/13 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| January 31, 2022 | 2022/6 Gaz | CA | Rejection |
| November 7, 2021 | 2021/45 Gaz | KR | Rejection |
| September 14, 2021 | 2021/37 Gaz | CH | Rejection |
| September 2, 2021 | 2021/40 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| May 27, 2021 | 2021/21 Gaz | NZ | Rejection |
| March 31, 2021 | 2021/13 Gaz | SG | Rejection |
| March 22, 2021 | 2021/17 Gaz | RAW: Limitation | |
| February 23, 2021 | 2021/9 Gaz | CN | Rejection |
| January 26, 2021 | 2021/4 Gaz | AU | Rejection |
| January 10, 2021 | 2021/3 Gaz | IL | Rejection |
| December 21, 2020 | 2020/52 Gaz | US | Rejection |
| August 11, 2020 | 2020/40 Gaz | EM | Registration |
ID: 141555226